Optometry

Latest News


CME Content


NSAID aids anti-VEGF drug

Results of a prospective, randomized pilot study suggest that a topical nonsteroidal anti-inflammatory drug, bromfenac 0.09%, may be a useful addition to an anti-vascular endothelial growth factor agent, intravitreal ranibizumab, in patients being treated for exudative age-related macular degeneration.

The UV + riboflavin crosslinking procedure triggers the development of mild stromal haze in rabbit corneas, but it is not because of myofibroblast generation,a s it is for late haze after PRK.

A number of procedures are available to address presbyopia, each with its advantages and disadvantages.

Careful investigation using a systematic approach to troubleshoot patients dissatisfied after multifocal IOL implantation usually can identify an underlying cause that can be effectively managed with conservative intervention and avoidance of further intraocular surgery.

Julia A. Haller, MD, details the complex medical case of a blind African teeneager recently freed from slavery in the Sudan.

A triple-function 23-gauge laser endoscope is available for video, imaging, and laser during an array of retinal procedures.

A new aspheric treatment for presbyopia, P-curve, considers both the total Q value and the corneal asphericity among other parameters to induce the negative spherical aberration that is lost with aging.

Results of a prospective, double-masked, randomized study indicate that combination treatment with the dexamethasone implant 0.7 mg and laser photocoagulation is very well tolerated in patients with DDME and provides better functional and anatomic outcomes than laser treatment alone.

Patients with severe or progressive zonulopathy are at risk for late postoperative subluxation or dislocation of a capsular tension ring-IOL-capsular bag complex, which occurred about 6 years after implantation.

Results from 2 years of follow-up in a study of presbyopia correction with femtosecond laser intrastromal correction show continued safety, refractive stability, and maintenance of improvements in near visual acuity.

Based on the fact that extraordinary customer service can be a game changer to help position your practice for success in this unstable economy, this article builds from last month's piece on customer service.

With the Office of Inspector General's heightened awareness of coding and documentation errors, physicians should be aware of some specific areas to check and double-check in their daily routine of documentation.

As results from the FDA IDE clinical trial are awaited, analyses of data from patients receiving earlier versions of an investigational presbyopia-correcting intracorneal inlay show that its efficacy for improving near vision remains stable for at least 3 years.

Bausch + Lomb and Technolas Perfect Vision hope the new femtosecond laser platform unveiled last month at the European Society of Cataract and Refractive Surgeons meeting will replace existing femtosecond laser systems.